Intensive insulin therapy reduced cardiovascular disease in type 1 diabetes

May 2006
ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p63
Academic Journal
The article discusses a study which aims to determine whether long-term intensive insulin therapy (IIT) reduces cardiovascular disease (CVD) events in patients with type 1 diabetes. 1441 patients between 13 to 40 years of age with type 1 diabetes were included in the study. Exclusion criteria were a history of CVD, hypertension or hypercholesterolemia. At mean 17 years, fewer patients in the IIT group had CVD events than did those in the conventional therapy group The study found that in patients with type 1 diabetes, long-term intensive insulin therapy reduced cardiovascular disease events.


Related Articles

  • Effects of Antidiabetic and Antihyperlipidemic Agents on C-Reactive Protein. Dandona, Paresh // Mayo Clinic Proceedings;Mar2008, Vol. 83 Issue 3, p333 

    Type 2 diabetes mellitus (DM) increases the risk of cardiovascular disease, a major cause of morbidity and mortality. Central to type 2 DM is insulin resistance, a proinflammatory, hypercoagulable state that predisposes patients to develop cardiovascular disease and that is associated with risk...

  • Beyond hypertension: Toward guidelines for cardiovascular risk reduction*. Volpe, Massimo; Alderman, Michael H.; Furberg, Curt D.; Jackson, Rodney; Kostis, John B.; Laragh, John H.; Psaty, Bruce M.; Ruilope, Luis M. // American Journal of Hypertension;Nov2004, Vol. 17 Issue 11, p1068 

    Most current clinical guidelines focus primarily on the management of individual cardiovascular risk factors, such as high blood pressure (BP), hypercholesterolemia, or diabetes. A more appropriate clinical approach to reducing cardiovascular disease risk would be based on a comprehensive...

  • Review: ACE inhibitors and angiotensin-receptor blockers reduce diabetes in hypertension and other CV risk factors.  // ACP Journal Club;Jan/Feb2007, Vol. 146 Issue 1, p11 

    The article discusses a research study regarding the effectiveness of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers in reducing new-onset diabetes mellitus. The study was conducted by researcher K.L. McCall and colleagues, and was published in the...

  • Aspirin use differs with men and women with diabetes.  // Patient Care;Jan2005, Vol. 39 Issue 1, p6 

    Discusses research being done to determine the extent of self-reported aspirin use among patients with diabetes. Reference to a study by S. D. Persell and D. W. Baker published in a 2004 issue of "Archives of Internal Medicine"; Percentage of aspirin use among diabetic adults with...

  • Endocrine.  // Modern Pathology;Sep2006 Suppelment 3, Vol. 19, p47 

    The article presents abstracts of medical research. They include "Evaluation of diabetic macro-and microangiopathies by digital thermography," "Persistent hyperinsulinemic hypoglycemia and nesidioblastosis after bariatric surgery" and "A pathological review of 13 cases of adrenocortical carcinoma."

  • Patrones de prescripción de antidiabéticos en un grupo de pacientes colombianos. Alba, Jorge Enrique Machado; Escobar, Juan Carlos Moncada; Escobar, Giovanny Mesa // Revista Panamericana de Salud Publica;Aug2007, Vol. 22 Issue 2, p124 

    Objectives. To identify prescription patterns for diabetes treatment among a group of individuals covered by Colombia's universal health care, the General System for Social Security in Health (SGSSS). Methods. The study included 7 308 patients covered by SGSSS who had diabetes mellitus type 1 or...

  • Insulin and Blood Glucose Control. Karl, E. // Diabetes Health;May2005, Vol. 14 Issue 5, p64 

    Provides information on the results of a study conducted by researchers from New England regarding the compliance of diabetics on chronic insulin therapy with insulin regimens as of May 2005. Number of diabetes patients who were involved in the study; Comparison of hypoglycemic agent use and...

  • Weekly basal-bolus adjustments may reduce HbA1c levels in patients with type 2 diabetes. Cypress, Aaron // Endocrine Today;9/10/2008, Vol. 6 Issue 16, p26 

    The article discusses findings of a multicenter, randomized, controlled trial conducted by researchers from the International Diabetes Center at Park Nicollet in Minneapolis, Minnesota and other U.S. sites, which compared a standard algorithm for adjusting glargine with two algorithms for...

  • Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies. Rckert, Ina-Maria; Schunk, Michaela; Holle, Rolf; Schipf, Sabine; V”lzke, Henry; Kluttig, Alexander; Greiser, Karin-Halina; Berger, Klaus; Mller, Grit; Ellert, Ute; Neuhauser, Hannelore; Rathmann, Wolfgang; Tamayo, Teresa; Moebus, Susanne; Andrich, Silke; Meisinger, Christa // Cardiovascular Diabetology;2012, Vol. 11 Issue 1, p50 

    Background: Although most deaths among patients with type 2 diabetes (T2D) are attributable to cardiovascular disease, modifiable cardiovascular risk factors appear to be inadequately treated in medical practice. The aim of this study was to describe hypertension, dyslipidemia and medical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics